# Methylene Blue (oral)

*Also known as: Methylene blue, Methylthioninium chloride, MB*

The attraction for lifters and biohackers is more energy, clearer focus and workouts that feel easier. Some people report trying methylene blue for those goals. Reports vary widely, and the small human cognition studies do not establish better strength, endurance or recovery.

Educational information only — not medical advice. Modelled values are not individual measurements or dosing recommendations.

## Dosage & duration

Oral cognitive research · no established daily wellness regimen

### Single-dose brain-imaging study

**Published example — product-specific**

- **Dose:** 280 mg, immediate-release oral capsule
- **How often:** One administration in the study
- **How long:** Same-day testing

Study context only: 26 healthy adults, with medication and health exclusions. This does not establish a starting dose, a daily routine or equivalence to drops.

- [Rodriguez et al. — randomized methylene blue brain-imaging trial](https://pmc.ncbi.nlm.nih.gov/articles/PMC5084971/) — 2016 randomized double-blind trial: 26 healthy adults, 13 received a single 280 mg immediate-release oral USP-grade capsule, 13 placebo. Short-term memory/imaging findings do not establish daily low-dose cognitive benefit, chronic safety or a wellness regimen.

The plot opens at 1 mg solely as a relative mathematical input. It does not propose an oral treatment amount; IV dosing is a separate clinical use.

Dose-context sources checked: 2026-10-09.

## At a glance

- **Why people try it:** Energy + mental clarity
- **Training interest:** Easier-feeling workouts
  Sources or review notes: [1](https://pmc.ncbi.nlm.nih.gov/articles/PMC5084971/).
- **Practical distinction:** Exact product + medicines
  Sources or review notes: [2](https://doi.org/10.1007/s00228-008-0563-x), [3](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4f6848e5-35ed-4046-b13c-3032b5ba3232), [4](https://www.mdanderson.org/cancerwise/methylene-blue-should-you-take-it.h00-159853767.html).

**Catalog evidence label (not clinical review):** Human clinical data

## Focus, energy and workout performance



| Goal | What people report | What remains uncertain |
| --- | --- | --- |
| Focus | Clearer thinking or motivation | Whether benefits persist beyond short-term testing |
| Energy | More daytime drive; others feel no change | Who benefits and how much is due to other changes |
| Training | Sets or cardio feel easier | Improved strength, endurance or recovery outcomes |

These are reported experiences, not a predictable effect checklist.

Visual sources checked: 2026-10-09.

- [Rodriguez et al. — randomized methylene blue brain-imaging trial](https://pmc.ncbi.nlm.nih.gov/articles/PMC5084971/) — 2016 randomized double-blind trial: 26 healthy adults, 13 received a single 280 mg immediate-release oral USP-grade capsule, 13 placebo. Short-term memory/imaging findings do not establish daily low-dose cognitive benefit, chronic safety or a wellness regimen.

## Overview

## Why does it show up in bodybuilding and biohacking?

Methylene blue is discussed for energy and mental clarity rather than as a muscle-building hormone. Some people describe it as mitochondrial support or report workouts feeling easier. For the reader, the useful question is what changed in everyday life or training—not simply whether a product affects mitochondria.

## What do people actually notice?

Reports range from clearer focus and more energy to no change, feeling on edge or trouble sleeping. Some people are taking several other supplements at the same time. A good workout or an enthusiastic first day cannot isolate which change caused it. The human study highlighted in the dose card examined a short-term memory task, not strength or conditioning progress.

## Is it a straightforward pre-workout?

There is no established pre-workout dose or timing from the reviewed human research. Feeling less exertion is different from proving better performance or safer cardiovascular strain. Sleep, perceived energy and actual training output are separate outcomes worth distinguishing.

## Why do the form and medication list matter?

Community questions often mix up oral liquids, capsules and injections. This page covers oral research; the IV medical product has a different use. Drop counts cannot be compared without knowing the concentration. A prescriber or pharmacist should check serotonergic medicines and relevant medical risks, including G6PD deficiency. Aquarium or industrial dye is not a medicinal substitute.

## Relative timing model

Relative oral timing

**Output:** Methylene Blue (oral): relative timing (relative units).

Compare timing and buildup for this compound. The values are not blood concentrations or a measure of strength.

Shows timing and dose scaling in relative units, not blood concentrations.

### Timing assumptions and scale

Walter-Sack 2009 Table 1: mean oral plasma half-life 18.3 h and Tmax 2.2 h after a single 500 mg aqueous solution in healthy adults. Transfer to other oral products or much lower doses is an assumption.

One 1 mg input peaks at 1 relative unit after a single dose. Other amounts scale proportionally; overlapping doses add when accumulation is on. Different compounds use separate relative scales.

- **Timing half-life used:** 18.3 hours
- **Absorption half-life assumed:** 0.3871067 hours
- **Reference amount for the relative scale:** 1 mg

- Absorption is inferred to reproduce the stated peak time with the stated terminal rate; this is not a fitted source absorption parameter.
- A single 1 mg input has a peak of 1 relative unit by definition. Repeated-dose addition and linear scaling are mathematical assumptions; the example dose does not calibrate the curve.
- Aqueous solution timing is not a validated model of capsules, lozenges, extended-release tablets or IV treatment.
- Plasma, whole-blood and reduced/oxidized species results are not interchangeable. No conversion from dye color or drops to a blood concentration is made.
- Peak-normalizing 3905 ng/mL at 18.3 h predicts more than twice the observed AUC∞ 51171 ng·h/mL, so this entry intentionally has no absolute calibration.

### Model sources

- [Walter-Sack et al. — aqueous oral methylene blue pharmacokinetics](https://doi.org/10.1007/s00228-008-0563-x) — Original 2009 crossover study, 16 healthy adults enrolled/15 completed. Table 1 oral 500 mg aqueous solution: plasma Cmax 3905 ng/mL, Tmax 2.2 h, half-life 18.3 h, AUC∞ 51171 ng·h/mL and AUC 0–24 33777. Full author-uploaded text reviewed. Sampling/matrix/formulation differ from IV and capsule studies.
- [Walter-Sack et al. — author-posted full text](https://www.researchgate.net/publication/23273151_High_absolute_bioavailability_of_methylene_blue_given_as_an_aqueous_oral_formulation) — Author-posted article includes Table 1 oral plasma means and Table 2 whole-blood means. These endpoints are not interchangeable; source oral dose 500 mg is a PK experiment, not a wellness dose.

**Revision:** methylene-blue-oral-relative-2026-10 · version 1

## Harm reduction

- **Interaction notes:** The IV label warns of potentially fatal serotonin syndrome and contraindicates use with G6PD deficiency because of hemolytic anemia. Oral research excluded important risk groups; exact oral risk cannot be inferred from the chart.

## Sources and review notes

Summary source check: 2026-10-09; see source notes 1. This does not certify medical review of the whole page.

### Notes on the quick facts

- **Why people try it:** These are reported goals, not established training benefits.
  Source check: 2026-10-09; not a medical review.
- **Training interest:** Some users describe this; it has not been established as a strength or endurance benefit.
  Source check: 2026-10-09; not a medical review.
- **Practical distinction:** Drops, capsules and IV products differ; serotonergic medicines are an important interaction check.
  Source check: 2026-10-09; not a medical review.

### References

1. [Rodriguez et al. — randomized methylene blue brain-imaging trial](https://pmc.ncbi.nlm.nih.gov/articles/PMC5084971/) — 2016 randomized double-blind trial: 26 healthy adults, 13 received a single 280 mg immediate-release oral USP-grade capsule, 13 placebo. Short-term memory/imaging findings do not establish daily low-dose cognitive benefit, chronic safety or a wellness regimen.
2. [Walter-Sack et al. — aqueous oral methylene blue pharmacokinetics](https://doi.org/10.1007/s00228-008-0563-x) — Original 2009 crossover study, 16 healthy adults enrolled/15 completed. Table 1 oral 500 mg aqueous solution: plasma Cmax 3905 ng/mL, Tmax 2.2 h, half-life 18.3 h, AUC∞ 51171 ng·h/mL and AUC 0–24 33777. Full author-uploaded text reviewed. Sampling/matrix/formulation differ from IV and capsule studies.
3. [DailyMed — Provayblue injection label](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4f6848e5-35ed-4046-b13c-3032b5ba3232) — IV product for acquired methemoglobinemia. Boxed serotonin-syndrome warning with serotonergic drugs/opioids, G6PD-related hemolytic-anemia contraindication. Injection doses and 24 h PK are not used to calibrate this oral entry.
4. [UT MD Anderson — methylene blue uses and risks](https://www.mdanderson.org/cancerwise/methylene-blue-should-you-take-it.h00-159853767.html) — First-party clinician explanation of medical use, unproven wellness claims, quality concerns and potentially serious interactions; used for readable risk framing.
5. [Walter-Sack et al. — author-posted full text](https://www.researchgate.net/publication/23273151_High_absolute_bioavailability_of_methylene_blue_given_as_an_aqueous_oral_formulation) — Author-posted article includes Table 1 oral plasma means and Table 2 whole-blood means. These endpoints are not interchangeable; source oral dose 500 mg is a PK experiment, not a wellness dose.

---

**Canonical URL:** https://anabolicplotter.com/compounds/methylene-blue/
**Methodology:** https://anabolicplotter.com/methodology/
**Plot:** https://anabolicplotter.com/plot?compound=methylene-blue